Shionogi, a leading Japanese pharmaceutical company, has joined the CMAC consortium, marking a pivotal step in global collaboration and innovation. Renowned for addressing unmet medical needs, Shionogi brings valuable regulatory insights and deep scientific expertise to CMAC’s international network.
Read MoreThe CMAC Data Lab is entering a transformative era in drug development and manufacturing. As part of CMAC’s commitment to innovation and research excellence, we’ve integrated cutting-edge Knowledge Graph software from Plvs Ultra into our research facility.
Read More